Created at	Source	Raw Value	Validated value
Nov. 26, 2021, 10:30 p.m.	oms	1.Number of subjects with laboratory confirmed COVID-19 infection among HCWs <br/ >2.Number of subjects with laboratory confirmed COVID-19 infection among other high-risk subjects <br/ >3.Number of laboratory confirmed COVID-19 infection with severe; critical or life-threatening disease as assessed by Investigator among HCWs <br/ >4.Number of laboratory confirmed COVID-19 infection with severe; critical or life-threatening disease as assessed by Investigator among other high-risk subjectsTimepoint: up to 6 months (180 days) following vaccine administration	1.Number of subjects with laboratory confirmed COVID-19 infection among HCWs <br/ >2.Number of subjects with laboratory confirmed COVID-19 infection among other high-risk subjects <br/ >3.Number of laboratory confirmed COVID-19 infection with severe; critical or life-threatening disease as assessed by Investigator among HCWs <br/ >4.Number of laboratory confirmed COVID-19 infection with severe; critical or life-threatening disease as assessed by Investigator among other high-risk subjectsTimepoint: up to 6 months (180 days) following vaccine administration
Nov. 13, 2021, 5:33 p.m.	oms	N/A	N/A
Oct. 26, 2020, 8:29 a.m.	oms	1.Number of subjects with laboratory confirmed COVID-19 infection among HCWs <br/ >2.Number of subjects with laboratory confirmed COVID-19 infection among other high-risk subjects <br/ >3.Number of laboratory confirmed COVID-19 infection with severe; critical or life-threatening disease as assessed by Investigator among HCWs <br/ >4.Number of laboratory confirmed COVID-19 infection with severe; critical or life-threatening disease as assessed by Investigator among other high-risk subjectsTimepoint: up to 6 months (180 days) following vaccine administration	1.Number of subjects with laboratory confirmed COVID-19 infection among HCWs <br/ >2.Number of subjects with laboratory confirmed COVID-19 infection among other high-risk subjects <br/ >3.Number of laboratory confirmed COVID-19 infection with severe; critical or life-threatening disease as assessed by Investigator among HCWs <br/ >4.Number of laboratory confirmed COVID-19 infection with severe; critical or life-threatening disease as assessed by Investigator among other high-risk subjectsTimepoint: up to 6 months (180 days) following vaccine administration